After the CDC issued its 2016 Opioid Prescribing Guideline, which focused on recommendations for primary care physicians, many physicians greatly limited prescribing opioids. This was in response to the opioid epidemic in our country which had an impact on reducing opioid abuse. However, it also may have left patients undertreated for pain given the 2016 guideline’s emphasis on not prescribing opioids. In November 2022, the CDC issued updated guidance for a broader group of clinicians. This blog series provides an overview of the more-than-60-page CDC guidance. This first blog will provide an overview of what the guidance is intended to accomplish and how it is presented. Our attorneys are experienced in advising healthcare businesses and pain management practices. If you have pain management prescribing questions or would like to discuss this blog post, you may contact our healthcare and business law firm at (404) 685-1662 (Atlanta) or (706) 722-7886 (Augusta), or by email, firstname.lastname@example.org. You may also learn more about our law firm by visiting www.hamillittle.com.
First, the updated guidance “is intended for clinicians who are treating outpatients aged ≥18 years with acute (duration of <1 month), subacute (duration of 1–3 months), or chronic (duration of >3 months) pain, and excludes pain management related to sickle cell disease, cancer-related pain treatment, palliative care, and end-of-life care.” Continue reading ›